Search Results 1541-1550 of 12628 for transexamic
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Help Fund Research.
Wu SY, Parker B, Cunningham C, Shah S, Wannamaker EJ, Pham MD. Splenic and multifocal renal infarcts as a rare presentation of hereditary hemorrhagic ...
Shaffi SK, Fischer EG, Argyropoulos CP, Wagner B. Validation of the international IgAN risk-prediction tool in American Indians and Hispanics. Clin Nephrol.
This medicine is to be given only by or under the supervision of your doctor or other health care professional. This product is available in the following ...
The deadline to have twice the impact to advance healthcare research is May 15. Give Today · Find a doctor · Explore careers.
About this study. The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness ...
We are transforming healthcare! ... Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each ...
This multi-institutional, phase 2 clinical trial is studying two doses of pembrolizumab administered prior to surgery (neoadjuvant therapy) and 4 doses ...
Each person's genetic code is unique. Researchers focused on pharmacogenomics at Mayo Clinic are working to understand how these tiny DNA variations cause ...
The purpose of this study is to compare the effectiveness and safety of XEN to trabeculectomy in subjects with open angle glaucoma refractory to topical medical ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.